GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...

Collaboration will support Controlled Human Infection Model (CHIM) studies to accelerate development of effective and affordable RSV vaccinesNantes, France and Heidelberg, Germany, October 8, 2024 ...

Immunization appointments are now open for eligible Albertans. As of Monday (Oct. 7) both COVID-19 and influenza immunization ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

All infants are to be offered a vaccine against the respiratory syncytial (RS) virus from next year to cut the number of ...

Illness from RSV is considered an infectious disease, usually leading to an infection of the upper respiratory tract but ...

Quebec is rolling out its fall vaccination campaign against respiratory viruses, as contagion levels of COVID-19 and other ...

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...